Knee Cartilage Repair Market to Reach USD 2.4 Billion by 2020

The global knee cartilage repair market is estimated to reach USD 2.4 Billion in 2020, growing at a CAGR of 7.1% from 2016 to 2020, according to a market research report Knee Cartilage Repair Market 2013-2020, published by iHealthcareAnalyst, Inc.

Visit the Knee Cartilage Repair Market 2013-2020 report at http://www.ihealthcareanalyst.com/report/knee-cartilage-repair-market/

The global knee cartilage repair market report provides market size (Revenue USD Million 2013 to 2020), market share and forecasts growth trends (CAGR%, 2016 to 2020).

Articular cartilage is the soft white cartilage that covers the ends of the bones and helps joints to move smoothly. It also helps to absorb the forces throughout the knee. Early identification and treatment of articular cartilage damage can have a significant effect on outcomes for patients. X-rays are sometimes useful but an MRI scan provides doctors with the best pictures of the knee cartilages. By repairing or replacing the damaged cartilage before it completely wears out, the arthritic damage can be reversed and the joints preserved. With improvements to arthroscopes and higher resolution cameras, the procedure has become extremely effective for both the diagnosis and treatment of knee problems.

The global knee cartilage repair market segmentation is based on procedure types (arthroscopic chondroplasty, autologous chondrocyte implantation, cell-based cartilage resurfacing, implants transplant, microfracture, and osteochondral grafts transplantation, etc.). The global Knee Cartilage Repair market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global Knee Cartilage Repair market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

1. Procedure Type
1.1. Arthroscopic Chondroplasty
1.2. Autologous Chondrocyte Implantation
1.3. Cell-based Cartilage Resurfacing
1.4. Implants Transplant
1.5. Microfracture
1.6. Osteochondral Grafts Transplantation
1.7. Others

2. Geography (Region, Country)
2.1. North America (U.S., Canada)
2.2. Latin America (Brazil, Mexico, Rest of LA)
2.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
2.4. Asia Pacific (Japan, China, India, Rest of APAC)
2.5. Rest of the World

3. Company Profiles
3.1. B. Braun Melsungen AG
3.2. DePuy Synthes
3.3. Histogenics Corporation
3.4. ISTO Technologies, Inc.
3.5. MEDIPOST Co. Ltd.
3.6. Osiris Therapeutics, Inc.
3.7. Smith & Nephew plc
3.8. Stryker Corporation
3.9. TiGenix NV
3.10. Vericel Corporation
3.11. Zimmer Biomet Holdings, Inc.

iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.

iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.

Ana Aitawa
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Phone: (314) 736-9294.
Email: sales@ihealthcareanalyst.com
http://www.ihealthcareanalyst.com

This release was published on openPR.